Why We're Doing This: The Financi...

Why We're Doing This: The Financial Misincentives Behind U.S. Healthcare

Dirty Little Secrets: Telling the Truth on Healthcare by Hannah Mamuszka
S1 · E1
Aug 10, 2026
29:39

Episode notes

In the debut episode of Dirty Little Secrets, Hannah Mamuszka and Lena Chaihorsky introduce themselves and the podcast's central thesis: that the U.S. healthcare system is built on financial incentives that reward treatment over prevention and volume over value, systematically blocking patients from the best data-driven care. Mamuszka, a molecular biologist who moved from cancer drug development into diagnostics, and Chaihorsky, who came to the field through math and finance, each recount early-career moments when validated science was undervalued by the payment system — a high-risk-pregnancy test reimbursed at $11, and a urine test that could spare men unnecessary prostate biopsies but was resisted by urologists whose income depended on the procedure. They argue that patients meet the system at their most vulnerable, unable to shop as empowered consumers, and that misaligned incentives — including the ACA's medical loss ratio, which they contend removes insurers' incentive to cut costs — keep prices climbing. Citing research that rising premiums have eroded decades of middle-class wage gains, they make the case for a more consumer-driven, data-personalized system and invite listeners to start asking harder questions.

Key takeaways

  • The podcast's throughline: U.S. healthcare pays generously for treatment (surgery, drugs, hospitalizations) but poorly for the information — diagnostics, screening, risk data — that would let patients be treated as individuals rather than averages.
  • Fee-for-service can create perverse incentives: the hosts describe a validated test that could reduce unnecessary prostate biopsies going unused because biopsies are a revenue source — a systems problem, not a critique of individual doctors.
  • The ACA's medical loss ratio (insurers must spend 80–85% of premiums on care) is framed as a misincentive: since profit is a slice of a bigger pie, there's little reward for lowering total costs.
  • Rising premiums have quietly consumed middle-class wage growth, which the hosts argue should reframe healthcare from an abstract cost into a personal, paycheck-level issue.

Relevant links

Keywords

healthcare
pharma
health insurance